Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Do Advances in Neoadjuvant Therapy Influence How We Surgically Manage the Regional Lymphatics in Gastric Cancer?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Badgwell B. Multimodality therapy of localized gastric adenocarcinoma. J Natl Compr Cancer Netw. 2016;14(10):1321–1327.

    Article  CAS  Google Scholar 

  2. Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, et al. Nodal downstaging in gastric cancer patients: promising survival if ypN0 is achieved. Ann Surg Oncol. 2018;25(7):2012–2017.

    Article  Google Scholar 

  3. Giuliano AE, Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918–926.

    Article  Google Scholar 

  4. Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222.

    Article  Google Scholar 

  5. Allen CJ, Vreeland TJ, Newhook TE, et al. Prognostic value of lymph node yield after neoadjuvant chemoradiation for gastric cancer. Ann Surg Oncol. Epub. 2019. https://doi.org/10.1245/s10434-019-07840-8.

    Article  Google Scholar 

  6. Leong T, Smithers BM, Haustermans K, Michael M, Gebski V, Miller D, et al. TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC and CCTG. Ann Surg Oncol. 2017;24(8):2252–2258.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Casey J. Allen MD & Brian D. Badgwell MD

Authors
  1. Casey J. Allen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian D. Badgwell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian D. Badgwell MD.

Ethics declarations

Disclosures

Casey J. Allen and Brian D. Badgwell report no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections is a brief invited commentary on the article “Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer”, Ann Surg Oncol. Epub 24 Sep 2019. https://doi.org/10.1245/s10434-019-07840-8

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allen, C.J., Badgwell, B.D. ASO Author Reflections: Do Advances in Neoadjuvant Therapy Influence How We Surgically Manage the Regional Lymphatics in Gastric Cancer?. Ann Surg Oncol 27, 543–544 (2020). https://doi.org/10.1245/s10434-019-07993-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07993-6

Search

Navigation